Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.06
PX's Cash-to-Debt is ranked lower than
93% of the 1086 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.93 vs. PX: 0.06 )
Ranked among companies with meaningful Cash-to-Debt only.
PX' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.01 Max: 0.14
Current: 0.06
0
0.14
Equity-to-Asset 0.26
PX's Equity-to-Asset is ranked lower than
88% of the 1047 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.56 vs. PX: 0.26 )
Ranked among companies with meaningful Equity-to-Asset only.
PX' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.16  Med: 0.31 Max: 0.41
Current: 0.26
0.16
0.41
Interest Coverage 11.78
PX's Interest Coverage is ranked lower than
66% of the 958 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 38.76 vs. PX: 11.78 )
Ranked among companies with meaningful Interest Coverage only.
PX' s Interest Coverage Range Over the Past 10 Years
Min: 9.51  Med: 14.58 Max: 17.28
Current: 11.78
9.51
17.28
Piotroski F-Score: 7
Altman Z-Score: 3.30
Beneish M-Score: -2.76
WACC vs ROIC
7.33%
11.27%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 21.25
PX's Operating Margin % is ranked higher than
91% of the 1061 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 7.15 vs. PX: 21.25 )
Ranked among companies with meaningful Operating Margin % only.
PX' s Operating Margin % Range Over the Past 10 Years
Min: 17.44  Med: 21.25 Max: 22.01
Current: 21.25
17.44
22.01
Net Margin % 14.24
PX's Net Margin % is ranked higher than
86% of the 1063 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.22 vs. PX: 14.24 )
Ranked among companies with meaningful Net Margin % only.
PX' s Net Margin % Range Over the Past 10 Years
Min: 11.22  Med: 14.12 Max: 15.07
Current: 14.24
11.22
15.07
ROE % 30.39
PX's ROE % is ranked higher than
92% of the 1049 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 8.43 vs. PX: 30.39 )
Ranked among companies with meaningful ROE % only.
PX' s ROE % Range Over the Past 10 Years
Min: 21.52  Med: 27.7 Max: 31.88
Current: 30.39
21.52
31.88
ROA % 7.78
PX's ROA % is ranked higher than
72% of the 1087 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.37 vs. PX: 7.78 )
Ranked among companies with meaningful ROA % only.
PX' s ROA % Range Over the Past 10 Years
Min: 7.97  Med: 9.16 Max: 10.57
Current: 7.78
7.97
10.57
ROC (Joel Greenblatt) % 18.16
PX's ROC (Joel Greenblatt) % is ranked higher than
61% of the 1079 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 13.62 vs. PX: 18.16 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
PX' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 17.33  Med: 20.85 Max: 23.65
Current: 18.16
17.33
23.65
3-Year Revenue Growth Rate -2.80
PX's 3-Year Revenue Growth Rate is ranked lower than
65% of the 929 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.60 vs. PX: -2.80 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
PX' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -2.8  Med: 4.2 Max: 15.9
Current: -2.8
-2.8
15.9
3-Year EBITDA Growth Rate -2.40
PX's 3-Year EBITDA Growth Rate is ranked lower than
74% of the 830 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 8.90 vs. PX: -2.40 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
PX' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -2.4  Med: 8.5 Max: 23.7
Current: -2.4
-2.4
23.7
3-Year EPS without NRI Growth Rate -3.90
PX's 3-Year EPS without NRI Growth Rate is ranked lower than
70% of the 756 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9.40 vs. PX: -3.90 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
PX' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -3.9  Med: 12.8 Max: 41.7
Current: -3.9
-3.9
41.7
GuruFocus has detected 4 Warning Signs with Praxair Inc $PX.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» PX's 10-Y Financials

Financials (Next Earnings Date: 2017-04-26 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

PX Guru Trades in Q2 2016

Jerome Dodson 200,000 sh (New)
Caxton Associates 70,000 sh (New)
Jim Simons 326,500 sh (+949.84%)
Paul Tudor Jones 263,095 sh (+145.23%)
Manning & Napier Advisors, Inc 43,811 sh (+65.62%)
Tom Gayner 22,800 sh (+60.56%)
Steven Cohen 130,700 sh (+19.36%)
John Rogers 47,283 sh (+1.15%)
RS Investment Management 78,154 sh (+0.81%)
First Eagle Investment 1,719,423 sh (+0.33%)
Pioneer Investments 14,922 sh (unchged)
Wallace Weitz 194,126 sh (unchged)
Bernard Horn 42,965 sh (unchged)
John Hussman Sold Out
Louis Moore Bacon Sold Out
Diamond Hill Capital 948,437 sh (-1.41%)
PRIMECAP Management 1,704,370 sh (-2.12%)
Chris Davis 3,340,309 sh (-2.66%)
Ruane Cunniff 1,605,924 sh (-7.37%)
Tom Russo 2,900 sh (-56.88%)
Joel Greenblatt 11,840 sh (-92.52%)
» More
Q3 2016

PX Guru Trades in Q3 2016

First Eagle Investment 2,746,481 sh (+59.73%)
Tom Gayner 36,400 sh (+59.65%)
Wallace Weitz 197,606 sh (+1.79%)
Jerome Dodson 200,000 sh (unchged)
Pioneer Investments 14,922 sh (unchged)
Bernard Horn 42,965 sh (unchged)
John Rogers Sold Out
Tom Russo Sold Out
Joel Greenblatt Sold Out
Diamond Hill Capital 930,814 sh (-1.86%)
Manning & Napier Advisors, Inc 42,696 sh (-2.55%)
Ruane Cunniff 1,539,083 sh (-4.16%)
Chris Davis 3,165,236 sh (-5.24%)
PRIMECAP Management 1,562,670 sh (-8.31%)
Caxton Associates 50,000 sh (-28.57%)
Steven Cohen 68,100 sh (-47.90%)
Jim Simons 118,200 sh (-63.80%)
Paul Tudor Jones 78,900 sh (-70.01%)
» More
Q4 2016

PX Guru Trades in Q4 2016

Jim Simons 402,600 sh (+240.61%)
Steven Cohen 188,700 sh (+177.09%)
First Eagle Investment 4,033,935 sh (+46.88%)
Tom Gayner 48,400 sh (+32.97%)
Caxton Associates 65,000 sh (+30.00%)
Diamond Hill Capital 1,027,817 sh (+10.42%)
Wallace Weitz 210,317 sh (+6.43%)
Manning & Napier Advisors, Inc 44,118 sh (+3.33%)
Jerome Dodson 200,000 sh (unchged)
Pioneer Investments 14,922 sh (unchged)
Bernard Horn 42,965 sh (unchged)
Paul Tudor Jones Sold Out
PRIMECAP Management 1,549,470 sh (-0.84%)
Chris Davis 2,957,530 sh (-6.56%)
Ruane Cunniff 334,782 sh (-78.25%)
» More
Q1 2017

PX Guru Trades in Q1 2017

Jerome Dodson 285,000 sh (+42.50%)
Manning & Napier Advisors, Inc 46,123 sh (+4.54%)
» More
» Details

Insider Trades

Latest Guru Trades with PX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Chemicals » Specialty Chemicals    NAICS: 325199    SIC: 2869
Compare:NYSE:ECL, NYSE:LYB, NYSE:SHW, NYSE:PPG, OTCPK:AKZOY, OTCPK:GVDNY, OTCPK:COVTY, OTCPK:NDEKY, NYSE:ALB, OTCPK:RDSMY, NYSE:IFF, OTCPK:NPCPF, OTCPK:LZAGY, NYSE:VAL, OTCPK:BNTGY, OTCPK:SYIEY, NYSE:WLK, OTCPK:CHYHY, NYSE:AXTA, OTCPK:ALFFF » details
Traded in other countries:PXR.Germany,
Headquarter Location:USA
Praxair Inc is engaged in the production, distribution, and sale of atmospheric and process gases, and surface coatings in North America, Europe, South America, and Asia. Its products include oxygen, helium, nitrogen, and specialty gases.

Praxair is the largest industrial gas supplier in North America and South America and among the largest globally. The company has a growing presence in Asia and a well-established presence in Europe. Its three main distribution businesses--on-site, merchant liquid, and packaged or cylinder gases--represent 29%, 34%, and 28% of sales, respectively. Praxair serves diverse industries, including healthcare, petroleum refining, aerospace, and chemicals. Revenue and operating income in 2015 totaled $10.8 billion and $2.5 billion, respectively.

Guru Investment Theses on Praxair Inc

Weitz Funds Comments on Praxair - Nov 16, 2015

Praxair (NYSE:PX) is an industrial gas supplier of Oxygen, Argon, Hydrogen and Helium in North and South America, Asia and Europe. These gases are integral to many industrial processes yet are often a tiny fraction of overall production costs. As a result, the industry is consolidated with only four global rational participants, which translates into pricing power for Praxair. Roughly a quarter of the company’s industrial gas production is under “take or pay” arrangements, providing coverage of fixed costs in downturns. Praxair management has proven to be excellent operators and capital allocators. The recent industrial sector downturn provided an opportunity for purchase. Prior to purchase, the company had been on our “On-Deck” list for several years.





From Weitz Funds' Partners III Opportunity Fund third quarter 2015 commentary.



Check out Wallace Weitz latest stock trades

Top Ranked Articles about Praxair Inc

Ruane Cunniff Sells Berkshire and Praxair, Exits Walmart The guru's largest 4th-quarter deals
Ruane, Cunniff & Goldfarb Inc. was founded by William Ruane, and Ruane Cunniff (TradesPortfolio)'s current investment committee is directed by Richard Cunniff. He manages a portfolio composed of 92 stocks with a total value of $10.642 billion. During the fourth quarter the guru sold shares in the following stocks: Read more...
Pelangio Reports Annual General Meeting Voting Results and Reports Filing of First Quarter Results for 2016

TORONTO, ONTARIO--(Marketwired - May 31, 2016) - Pelangio Exploration Inc. (TSX VENTURE:PX)(OTC PINK:PGXPF) ("Pelangio" or the "Company") announces the voting results from its Annual General Meeting of Shareholders held on May 26, 2016 (the "Meeting"). Pelangio's shareholders voted in favour of all items of business at the 2016 Annual General Meeting held on May 26, 2016. A total of 98,280,521 (42.83%) of Pelangio's common shares were represented at the meeting. The six nominees listed in the Management proxy circular were elected as directors of Pelangio. Detailed results of the vote for the election of directors are set out below.


NOMINEE
Votes For
% For
Votes Withheld
% Withheld


Ingrid Hibbard
90,072,772
99.91
84,351
0.09


Philip Olson
90,061,772
99.89
95,351
0.11


Thor Eaton
90,059,772
99.89
97,351
0.11


David Mosher
90,054,772
99.89
102,351
0.11


Carl Nurmi
90,082,772
99.92
74,851
0.08


Ian Shaw
90.055,772
99.89
101,351
0.11



First Quarter Results Also today, Pelangio announces financial and operational results for the three months ended March 31, 2016. Financial reports and Management's Discussion and Analysis are available on both the Company's website (www.pelangio.com) and SEDAR (www.sedar.com). Q1 2016 Operational Highlights

Manfo - in preparation for drilling, a detailed interpretation continued on a laterite covered major structure identified in 2015 lying to the east of the currently explored structure



Obuasi - technical review of exploration along a gold and arsenic in soil anomaly (the "NGA trend") underway in preparation for further drilling



Akroma - paper studies, including the use of satellite imagery, indicate that substantial galamsey (local artisanal mining) and unregulated mechanized alluvial operations surrounding the project were carried out during 2014-2015. These alluvial operations appear to be sourced by large gold-in-soil anomalies on the Pelangio Dormaa Concession



Poirier - prepared a three dimensional geologic model using all available public data and a three dimensional magnetic inversion which indicates that the favourable structure hosting the Rusk and Gap zones dips into the Poirier property



Canadian Mining EXPO 2016 - The Big Event Pelangio will be presenting and exhibiting at "The Big Event" held Wednesday June 1 and Thursday June 2, 2016 in Timmins, Ontario. Pelangio's President and CEO, Ingrid Hibbard, will be giving a presentation about the Company at the Investors Forum on June 2 at 2:10 pm. About Pelangio Pelangio successfully acquires and explores camp-sized land packages in world-class gold belts, while using innovative corporate restructuring to maximize shareholder value. The Company primarily operates in Ghana, West Africa, an English-speaking, common law jurisdiction that is consistently ranked amongst the most favourable mining jurisdictions in Africa. The Company is exploring three 100%-owned camp-sized properties: the 100 km2 Manfo Property, the site of seven recent near-surface gold discoveries, the 264 km2 Obuasi Property, located four kilometres on strike and adjacent to AngloGold Ashanti's prolific, high-grade Obuasi Mine, which has produced over 30 million ounces of gold since 1897, and the early-stage 159 km2 Akroma Property. For additional information, please visit our website at www.pelangio.com, follow us on Twitter @PelangioEx. Forward-Looking Statements Certain statements herein may contain forward-looking statements and forward-looking information within the meaning of applicable securities laws. Forward-looking statements or information appear in a number of places and can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate" or "believes" or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements and information include statements regarding the private placement, the proposed use of proceeds and the Company's exploration plans and drill program. With respect to forward-looking statements and information contained herein, we have made numerous assumptions, including assumptions about the state of the equity markets. Such forward-looking statements and information are subject to risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statement or information. Such risks include changes in equity markets, share price volatility, volatility of global and local economic climate, gold price volatility, political developments in Ghana, increases in costs, exchange rate fluctuations, speculative nature of gold exploration and other risks involved in the gold exploration industry. See the Company's annual and quarterly financial statements and management's discussion and analysis for additional information on risks and uncertainties relating to the forward-looking statement and information. There can be no assurance that a forward-looking statement or information referenced herein will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements or information. Also, many of the factors are beyond the control of the Company. Accordingly, readers should not place undue reliance on forward-looking statements or information. We undertake no obligation to reissue or update any forward-looking statements or information except as required by law. All forward-looking statements and information herein are qualified by this cautionary statement. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.





Pelangio Exploration Inc.
Ingrid Hibbard
President & CEO
Pelangio Exploration Inc.
Warren Bates
Vice President Exploration
905-336-3828
Toll-free: 1-877-746-1632
[email protected]




Read more...

Ratios

vs
industry
vs
history
PE Ratio 22.91
PX's PE Ratio is ranked lower than
55% of the 866 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 20.14 vs. PX: 22.91 )
Ranked among companies with meaningful PE Ratio only.
PX' s PE Ratio Range Over the Past 10 Years
Min: 13.02  Med: 21.28 Max: 25.85
Current: 22.91
13.02
25.85
Forward PE Ratio 20.79
PX's Forward PE Ratio is ranked lower than
67% of the 201 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 18.35 vs. PX: 20.79 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 22.91
PX's PE Ratio without NRI is ranked lower than
55% of the 866 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 20.26 vs. PX: 22.91 )
Ranked among companies with meaningful PE Ratio without NRI only.
PX' s PE Ratio without NRI Range Over the Past 10 Years
Min: 13.02  Med: 21.28 Max: 25.85
Current: 22.91
13.02
25.85
Price-to-Owner-Earnings 33.96
PX's Price-to-Owner-Earnings is ranked lower than
72% of the 487 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 19.07 vs. PX: 33.96 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
PX' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 15.55  Med: 26.97 Max: 39.83
Current: 33.96
15.55
39.83
PB Ratio 6.80
PX's PB Ratio is ranked lower than
89% of the 1048 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.99 vs. PX: 6.80 )
Ranked among companies with meaningful PB Ratio only.
PX' s PB Ratio Range Over the Past 10 Years
Min: 3.39  Med: 5.42 Max: 7.69
Current: 6.8
3.39
7.69
PS Ratio 3.26
PX's PS Ratio is ranked lower than
75% of the 1035 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.34 vs. PX: 3.26 )
Ranked among companies with meaningful PS Ratio only.
PX' s PS Ratio Range Over the Past 10 Years
Min: 1.58  Med: 2.92 Max: 3.39
Current: 3.26
1.58
3.39
Price-to-Free-Cash-Flow 26.30
PX's Price-to-Free-Cash-Flow is ranked lower than
71% of the 412 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 17.20 vs. PX: 26.30 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
PX' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 23.64  Med: 40.09 Max: 123.98
Current: 26.3
23.64
123.98
Price-to-Operating-Cash-Flow 12.40
PX's Price-to-Operating-Cash-Flow is ranked lower than
60% of the 493 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 10.40 vs. PX: 12.40 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
PX' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.72  Med: 12.35 Max: 18.83
Current: 12.4
8.72
18.83
EV-to-EBIT 19.46
PX's EV-to-EBIT is ranked lower than
60% of the 1124 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 16.80 vs. PX: 19.46 )
Ranked among companies with meaningful EV-to-EBIT only.
PX' s EV-to-EBIT Range Over the Past 10 Years
Min: 10.9  Med: 17.5 Max: 23.1
Current: 19.46
10.9
23.1
EV-to-EBITDA 12.93
PX's EV-to-EBITDA is ranked lower than
54% of the 1142 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 12.25 vs. PX: 12.93 )
Ranked among companies with meaningful EV-to-EBITDA only.
PX' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.7  Med: 12.1 Max: 14.4
Current: 12.93
7.7
14.4
PEG Ratio 32.71
PX's PEG Ratio is ranked lower than
94% of the 445 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.97 vs. PX: 32.71 )
Ranked among companies with meaningful PEG Ratio only.
PX' s PEG Ratio Range Over the Past 10 Years
Min: 0.82  Med: 2.15 Max: 37.68
Current: 32.71
0.82
37.68
Shiller PE Ratio 22.96
PX's Shiller PE Ratio is ranked higher than
80% of the 182 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 36.52 vs. PX: 22.96 )
Ranked among companies with meaningful Shiller PE Ratio only.
PX' s Shiller PE Ratio Range Over the Past 10 Years
Min: 19.88  Med: 29.46 Max: 42.08
Current: 22.96
19.88
42.08
Current Ratio 1.16
PX's Current Ratio is ranked lower than
78% of the 957 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.86 vs. PX: 1.16 )
Ranked among companies with meaningful Current Ratio only.
PX' s Current Ratio Range Over the Past 10 Years
Min: 0.44  Med: 1.07 Max: 1.39
Current: 1.16
0.44
1.39
Quick Ratio 0.94
PX's Quick Ratio is ranked lower than
72% of the 957 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.36 vs. PX: 0.94 )
Ranked among companies with meaningful Quick Ratio only.
PX' s Quick Ratio Range Over the Past 10 Years
Min: 0.35  Med: 0.84 Max: 1.11
Current: 0.94
0.35
1.11
Days Inventory 34.02
PX's Days Inventory is ranked higher than
81% of the 1022 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 65.16 vs. PX: 34.02 )
Ranked among companies with meaningful Days Inventory only.
PX' s Days Inventory Range Over the Past 10 Years
Min: 24.16  Med: 27.15 Max: 33.67
Current: 34.02
24.16
33.67
Days Sales Outstanding 52.63
PX's Days Sales Outstanding is ranked higher than
62% of the 858 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 59.97 vs. PX: 52.63 )
Ranked among companies with meaningful Days Sales Outstanding only.
PX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 48.89  Med: 53.96 Max: 66.89
Current: 52.63
48.89
66.89
Days Payable 56.43
PX's Days Payable is ranked higher than
57% of the 814 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 49.46 vs. PX: 56.43 )
Ranked among companies with meaningful Days Payable only.
PX' s Days Payable Range Over the Past 10 Years
Min: 45.3  Med: 51.65 Max: 56.43
Current: 56.43
45.3
56.43

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 2.54
PX's Dividend Yield % is ranked higher than
73% of the 1115 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.83 vs. PX: 2.54 )
Ranked among companies with meaningful Dividend Yield % only.
PX' s Dividend Yield % Range Over the Past 10 Years
Min: 1.31  Med: 1.96 Max: 2.94
Current: 2.54
1.31
2.94
Dividend Payout Ratio 0.58
PX's Dividend Payout Ratio is ranked lower than
65% of the 743 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.32 vs. PX: 0.58 )
Ranked among companies with meaningful Dividend Payout Ratio only.
PX' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.33  Med: 0.4 Max: 0.58
Current: 0.58
0.33
0.58
3-Year Dividend Growth Rate 7.70
PX's 3-Year Dividend Growth Rate is ranked higher than
51% of the 536 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 7.70 vs. PX: 7.70 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
PX' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 13.8 Max: 47
Current: 7.7
0
47
Forward Dividend Yield % 2.63
PX's Forward Dividend Yield % is ranked higher than
72% of the 1079 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.94 vs. PX: 2.63 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 3.84
PX's 5-Year Yield-on-Cost % is ranked higher than
73% of the 1281 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.30 vs. PX: 3.84 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
PX' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.98  Med: 2.96 Max: 4.44
Current: 3.84
1.98
4.44
3-Year Average Share Buyback Ratio 1.00
PX's 3-Year Average Share Buyback Ratio is ranked higher than
88% of the 486 Companies
in the Global Specialty Chemicals industry.

( Industry Median: -1.60 vs. PX: 1.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
PX' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -5.1  Med: 0.2 Max: 1.5
Current: 1
-5.1
1.5

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 25.83
PX's Price-to-Tangible-Book is ranked lower than
98% of the 996 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.15 vs. PX: 25.83 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
PX' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3  Med: 7.5 Max: 34.94
Current: 25.83
3
34.94
Price-to-Intrinsic-Value-Projected-FCF 2.60
PX's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
74% of the 519 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.41 vs. PX: 2.60 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
PX' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.78  Med: 2.57 Max: 4.34
Current: 2.6
1.78
4.34
Price-to-Median-PS-Value 1.12
PX's Price-to-Median-PS-Value is ranked higher than
68% of the 952 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.32 vs. PX: 1.12 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
PX' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.29  Med: 0.76 Max: 1.12
Current: 1.12
0.29
1.12
Price-to-Graham-Number 5.13
PX's Price-to-Graham-Number is ranked lower than
90% of the 707 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.35 vs. PX: 5.13 )
Ranked among companies with meaningful Price-to-Graham-Number only.
PX' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.55  Med: 2.53 Max: 5.45
Current: 5.13
1.55
5.45
Earnings Yield (Greenblatt) % 5.14
PX's Earnings Yield (Greenblatt) % is ranked lower than
51% of the 1290 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.25 vs. PX: 5.14 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
PX' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 4.3  Med: 5.7 Max: 9.2
Current: 5.14
4.3
9.2
Forward Rate of Return (Yacktman) % 3.53
PX's Forward Rate of Return (Yacktman) % is ranked lower than
61% of the 606 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 8.09 vs. PX: 3.53 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
PX' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 3.4  Med: 11.5 Max: 19.1
Current: 3.53
3.4
19.1

More Statistics

Revenue (TTM) (Mil) $10,534
EPS (TTM) $ 5.22
Beta1.13
Short Percentage of Float1.67%
52-Week Range $106.31 - 125.00
Shares Outstanding (Mil)285.28

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 10,840 11,500 11,923
EPS ($) 5.73 6.35 6.84
EPS without NRI ($) 5.73 6.35 6.84
EPS Growth Rate
(Future 3Y To 5Y Estimate)
12.90%
Dividends per Share ($) 3.22 3.47 3.77
» More Articles for PX

Headlines

Articles On GuruFocus.com
Dividend Aristocrats in Focus Part 9: Air Products & Chemicals Oct 20 2016 
Jerome Dodson Goes 3 for 3 in Second Quarter Jul 21 2016 
Pelangio Reports Annual General Meeting Voting Results and Reports Filing of First Quarter Results f May 31 2016 
Pelangio Grants Options and Provides Update Jan 19 2016 
Weekly CEO Buys Highlight: FS Investment, Opko, Ambac, Calamos, Praxair Jan 11 2016 
Dividend Aristocrats Part 40: Air Products & Chemicals Jan 06 2016 
Praxair: Strong Dividend Growth With Macro Challenges Dec 18 2015 
Weitz Funds Comments on Praxair Nov 16 2015 
Praxair Inc. Insider Buys Company Shares Sep 25 2015 
Weekly CEO Buys Highlight: CC, OPK, PX, PSG, JOY Sep 12 2015 

More From Other Websites
What's in Store for Material ETFs in Q1 Earnings? Apr 21 2017
Praxair Named to Corporate Responsibility Magazine’s 100 Best Corporate Citizens List™ for Fifth... Apr 20 2017
Praxair Expands in Indiana with New ASU, Boosts Services Apr 18 2017
Praxair Commissions Air Separation Plant on Burns Harbor, Indiana, Pipeline System Apr 17 2017
Praxair, Inc. breached its 50 day moving average in a Bearish Manner : PX-US : April 14, 2017 Apr 14 2017
Linde-Praxair merger deal falls behind schedule -source Apr 13 2017
Linde-Praxair agreement will not be ready by May 10 AGM -source Apr 13 2017
Linde rejects request to vote on Praxair merger at AGM Apr 11 2017
Munich prosecutors not starting probe of Linde Chairman Reitzle Apr 07 2017
Linde board still equally divided on Praxair merger -source Apr 06 2017
Top Research Reports for Today: MSFT, TSLA, PNC Apr 03 2017
Praxair, Inc. : PX-US: Dividend Analysis : March 07th, 2017 (record date) : By the numbers : April... Apr 03 2017
Praxair Announces First Quarter 2017 Earnings and Conference Call Schedule Apr 03 2017
Linde chairman ready to use casting vote for Praxair merger: FT Apr 03 2017
How APD Is Trading Compared to Its Peer Mar 31 2017
Linde works council chief says to vote against Praxair merger Mar 30 2017
Unions threaten to scupper Linde-Praxair merger Mar 30 2017
Praxair-Linde merger opposed by European works council Mar 29 2017
Praxair Unit Wins Rolls-Royce's 10-year Coating Contract Mar 29 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)